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Lower body negative pressure (LBNP) 
treatment, also known as intermittent vacuum 
therapy, was developed for astronauts, to 
maintain the arterial blood supply of the lower 
body and compensate for weightlessness. Due 
to the low gravity in space, autonomic cardiovascular control 
deteriorates and orthostatic tolerance is re-established by 
means of LBNP therapy after exploration flights.[1]  
Designed to act as an external heart for the lower body, the 
LBNP device generates a rhythmic alternating pressure of 
intermittent waves of negative pressure (lower pressure), and 
normal pressure (atmospheric pressure). As described in 
available literature this mechanism causes strong capillary 
dilation and compression pulsations[2] through which blood 
circulation and perfusion in the lower limbs are increased.[3] 
Arteries dilate as oxygen (O2)-rich blood and nutrients are 
drawn into the tissue (hypobaric), resulting in a higher 
available concentration of O2 and supplements in the muscle,[4] 
followed by an atmospheric pressure phase, a relief of the 
reflux, when carbon dioxide (CO2) and metabolic waste 
products are pressed back into the upper body through the 
circulatory system and the lymphatic vessels.[5] This application 
of sub-atmospheric pressure to the lower portion of the body 
(below the iliac crest) consequently enhances the baroreflex that 
assists in maintaining blood pressure during orthostatic 
stress.[1,2]  
In clinical applications, the use of negative pressure has been 
indicated as an effective modality.[4,6] A study by Schneider et 
al.[7] indicated an improvement in heart rate and blood pressure 
responses observed with the application of LBNP after 15 days 
of bed rest.  
Following excessive training, athletes often experience 
symptoms of discomfort, muscular soreness and stiffness 
within 12–24h, which can contribute to the development of 
muscular fatigue resulting in deteriorating performance.[8,9] 
Delayed onset muscle soreness (DOMS) is an inflammatory 
reaction caused by the micro-damage of primary muscle. Sports 
massage is a popular treatment and a frequently applied 
intervention; however, evidence to support its efficacy as a 
technique to enhance recovery is still being explored.[10] 
Appropriate methods of recovery are, however, essential to 
restore an athlete’s physiological and psychological capacities. 
Prompt and sufficient recovery can also improve performance 
by enhancing training quality and tolerance to the training load, 
as well as improving the athlete’s adaptation to training. 
Without proper recovery following multiple training sessions 
or competitions, an athlete increases the risk for poorer 
performance and overuse injuries.[8,10] Mimicking sports 
massage by stimulating the circulatory system and lymphatic 
vessels, LBNP is claimed to play a vital role in the recovery of 
the athlete in order to maximise athletic performance in 
competitive sport. 
The endurance capacity in athletes differs, with highly 
trained athletes performing at a higher maximal oxygen 
uptake, presenting with minimum lactate accumulation. 
During exercise of increasing intensity, an increase in blood 
lactate concentration is an indication of a rise in glycogen 
metabolism within the muscle. However, the initial increase in 
blood lactate concentration implies the net result of lactate 
production in the muscle, and reflects that the appearance rate 
of lactate in the blood is higher than the disappearance rate (the 
result of a balance between the rate of production and 
removal).[11,12] This is referred to as the lactate threshold and is
Background: Athletes need to recover fully to maximise 
performance in competitive sport.  Athletes who replenish 
more quickly and more efficiently are able to train harder and 
more intensely. Elite athletes subjectively report positive 
results using lower body negative pressure (LBNP) treatment 
as an alternate method for rapid recovery, restoring and 
improving their impaired physical state. Objective data on the 
efficacy are lacking. 
Objectives: To investigate the effect of intermittent vacuum 
therapy on accelerating acute recovery following an athlete’s 
normal daily training schedule of strenuous exercise. 
Objective measurements of biological markers of muscular 
fatigue were used to assess recovery. 
Methods: Twenty-two male cricket players in a randomised 
cross-over study were divided into a treatment and control 
group respectively. Following a one-hour high-intensity gym 
session, the treatment group received three 30-minute LBNP 
exposure sessions over three consecutive days (0, 24 and 48 
hours). Blood lactate and creatine kinase biomarkers were 
collected to measure the recovery process. After 14 days 
groups were crossed over and the trial repeated.  
Results: Heart rate and blood pressure decreased noticeably 
during treatment, reverting to baseline levels after treatment. 
Lactate concentrations decreased in both groups after exercise 
termination; significantly more in the treatment (0.57±0.23 
mmol/l) than control group (0.78±0.22 mmol/l), p<0.001). 
Creatine kinase (CK) was similar in both groups. Athletes’ 
subjective assessments of recovery rated moderately high. 
Conclusion: LBNP therapy applied as treatment during 
routine schedule may have a systemic effect in lowering serum 
lactate levels, but not CK levels. Enhanced recovery of athletes 
is still unconfirmed. 
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considered to be a good predictor of endurance exercise 
performance. The lactate threshold is often used to prescribe 
training intensities, based on the relationship between blood 
lactate levels and heart rate. In the same way, active recovery 
after strenuous exercise will clear the accumulated blood 
lactate levels faster than passive recovery. More so in an 
intensity-dependent manner, with maximum blood lactate 
clearance occurring with active recovery close to the lactate 
threshold.[12,13]  
The severity of muscle damage and injury is frequently 
monitored by blood serum CK enzyme activity levels.[14] 
Although debated by researchers, lactate concentration and 
blood serum CK activity levels are implemented as 
biomarkers in measuring the recovery process that is crucial 
for successful endurance capacity and sport 
performance.[12,13,14]  
Hormonal changes in the body are involved in regulating 
various physiological functions, and when activated are 
known to improve mental function and willpower, thus 
automatically increasing the subjective well-being of an 
individual.[15] The increased blood circulation in the entire 
body and brain achieved by the vacuum effect of the LBNP 
device may hypothetically also increase oxygen circulation 
and influence hormone levels and their release in the blood to 
enhance a feeling of perceived recovery experienced by the 
athletes, with the magnitude of improvement remaining of a 
perceptive nature. 
LBNP therapy is becoming popular through the promise of 
an innovative to optimise and accelerate sports recovery, 
increase physical performance and reduce breaks from 
training, with very little confirmed evidence. The objective of 
this study was to assess if intermittent negative pressure 
therapy applied to the lower body of athletes will affect 
known measures of muscular recovery and result in faster 
recovery time and recuperation.  
 
Methods 
Study design 
A randomised cross-over study design with repeated 
measures was performed to determine the effect negative 
pressure wave treatment has on the recovery of cricketers. An 
information letter with a full explanation regarding the nature 
of the study was given to all participants, and informed 
written consent forms were collected from each candidate 
prior to the study. The study protocol was approved by the 
Ethics Committee of the University of Pretoria, South Africa 
(Approval number 352/2013). 
 
Participants and selection criteria  
Twenty-two healthy male cricket players based at the TUKS 
Cricket Academy, at the High Performance Centre of the 
University of Pretoria, South Africa, were invited to 
participate. Players were randomly assigned to one of two 
groups and evaluated. After the second week the participants 
were crossed over and the study repeated over the following 
two weeks. Participant exclusion criteria included 
cardiovascular diseases, hypotony with proneness to collapse, 
diabetes, recent phlebotrombosis (<eight weeks), the risk of 
thromboembolism and smoking. Participants were instructed 
to refrain from drinking alcohol, and consuming caffeine 
products 24 hours prior to each study session. 
 
Study procedure  
All participants documented their personal information and 
history before the start of the study. The age, body mass, height 
and body mass index (BMI) of each athlete were recorded at the 
start of the study. Each player participated in the cross-over 
design during the four week study period: once in the 
treatment group (receiving LBNP treatment; ExT) and once in 
the control group (not receiving LBNP treatment; ExC). The 
two applications were separated by a washout period of 14 
days. Each trial assessment was completed over three 
consecutive days and followed the same routine physical, 
physiological and treatment conduct as illustrated in Figure 1. 
The cricket players continued to follow their regular weekly 
physical training programme consisting of seven hours 
conditioning and 10 hours cricket specific skills, with one 
competitive match on weekends, throughout the study period. 
 
Protocol 
On the first day of the trial (Figure 1) baseline physiological 
measurements (heart rate (HR); blood pressure (BP); blood 
oxygen saturation (SpO2)) and blood samples (Lactate (Lac); 
Creatine Kinase (CK)) were collected from the participating 
athletes pre-exercise. Participants then completed a one hour 
high-intensity gym session comprising of weighted exercises 
and plyometric upper and lower limb training. Directly after 
the exercise session, physiological measurements and blood 
sample collection were repeated. Players were randomly 
assigned to either receive one 30 minute LBNP treatment 
session (ExT) or remain seated in the treatment room with no 
exposure (ExC). A questionnaire (based on an ordinal rating 
scale of one to five) was completed by each player before and 
after every LBNP treatment session, to quantify their perceived 
recovery state (Table 1). Normal training proceeded in the 
afternoon and the players returned on Day Two and Day Three 
during which the same athletes once more received either a 
treatment session or remained unexposed. Physiological 
measurements and blood samples were collected daily before 
and during each treatment session, for both the treatment (ExT) 
and control (ExC) participants. Treatment sessions were 
labelled as: 0 hours after, 24 hours after and 48 hours after 
intense training. 
 
LBNP vacuum therapy 
The LBNP device for intermittent vacuum therapy comprises of 
a cylinder-shaped chamber into which the lower body of the 
athlete is placed. The athlete lies on his back, his legs and lower 
body up to the iliac crest bone, inside the chamber. The 
chamber, enfolding the lower body of the athlete, is sealed by 
means of a diaphragm (iris seal) around the waist. Alternating 
negative and normal pressure is generated in the chamber by a 
vacuum pump. The device generates rhythmic interchanging 
pressure waves of normal pressure (atmospheric pressure) and 
negative pressure (lower pressure) at alternating pulsations. A 
vacuum treatment with negative pressure setting of 68 mbar 
was regulated, with an atmospheric pressure:negative pressur
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alternating phase duration of 9:6 seconds. The LBNP device 
used during this study period was voluntarily supplied by 
Rapid Sports Medical Regeneration, South Africa. 
Physiological measurements 
Vital health assessments - heart rate (HR), blood pressure (BP) 
and blood oxygen saturation (SpO2) - were noted throughout 
the study, for both the ExT and the ExC athletes. SpO2 (oxy-
haemoglobin and deoxy-haemoglobin in the red blood cells) 
was monitored using a Finger Pulse Oximeter Probe (Anapulse 
ANP150). 
 
Blood lactate concentration  
A small blood sample (0.3µl) was collected by means of a lancet 
prick of the earlobe to determine the blood lactate 
concentration (mmol/l) of all athletes (both the ExT group and 
the ExC group). Analysis was performed using Lactate Pro™2 
test strips (Batch# B133B03L) and a portable blood lactate 
analyser (Arkray Pro2 LT-1730). Lactate was sampled at rest on 
Day One (Lac0), immediately after the one hour exercise 
session (Lac1) and directly after the first 30 min LBNP 
treatment session (Lac2). 
 
Serum creatine kinase enzyme activity levels (CK) 
CK levels (IU/litre enzyme activity) were assessed from 
approximately five ml of blood drawn from an antecubital vein 
by venipuncture. Blood samples were obtained at baseline and 
at 0 hours, 24 hours and 48 hours respectively after treatment 
and were analysed (Creatine Phosphokinase Assay; Beckman 
UniCel® DxC800 Synchron) to determine possible increases in 
CK blood serum levels.    
 
Perceived recovery questionnaire 
The questionnaire was based on an ordinal rating scale of one 
to five, to evaluate the perceived amount of recovery with 
LBNP therapy (of all athletes: ExC and ExT). The questions 
were designed to explore the subjective perceptions of their 
intensity of muscle soreness and their level of recovery, 
comparing pre-treatment and post-treatment on the LBNP 
device (Table 1). Athletes belonging to the ExT group were also 
questioned on their opinion of the effectiveness of LBNP 
therapy. 
 
Data analysis 
The data analysis consisted of descriptive statistics to 
Table 1. Perceived recovery questionnaire 
Question Ordinal rating scale 
1                                       5 
Pre-treatment:  
How does your body 
feel after exercise / 
before treatment? 
Extremely 
exhausted 
Excellent 
condition 
How do your muscles 
feel? 
Very heavy Excellent 
condition 
How does your body 
feel in terms of fatigue? 
 
I feel extremely 
fatigued 
I feel fully 
energised 
Post-treatment:  
How do your muscles 
feel? 
Very heavy Excellent 
condition 
How does your body 
feel in terms of fatigue? 
I feel extremely 
fatigued 
I feel fully 
energised 
How well rested and 
regenerated do you feel? 
 
Not recovered Very well 
recovered 
LBNP effectiveness:  
How do you feel after 
your treatment session 
on the LBNP device? 
My body still 
feels tired/ 
fatigued 
My body feels in 
great condition 
Do you have the 
impression that the 
LBNP device helped? 
Not impressed Extremely 
impressed 
 
 
 
 
Table 2. Baseline physical characteristics of participants (N=22) 
Variables 
 
Mean ± SD 
Age (years) 20±1 
Body weight (kg) 79.6±8.2 
Height (cm) 180.0±0.1 
BMI (kg/m2) 24.6±2.5 
 
 
. 
 
 
Fig.1. Procedure of physiological measurements and blood samples taken over three consecutive trial days. **Intervention starts. HR, heart 
rate; BP, blood pressure; SpO2, blood oxygen saturation; CK,  creatine kinase; Lac,  lactate; QU, questionnaire.  
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summarise the quantitative information. Repeated measures 
ANOVA was used to assess the changes in blood lactate 
concentration and CK activity levels over the 48 hour 
treatment period between the treatment and control groups. 
The proportional changes (after vs. before) of the treatment 
were evaluated and interpreted as follows: values smaller 
than one indicate a decrease, values larger than one an 
increase and a value of one would indicate no change took 
place.  
The results of the perceived recovery questionnaire were 
combined into pre-treatment recovery scores and post-
treatment recovery scores. Non-parametric Mann-Whitney U 
tests were performed to determine differences between the 
treatment and control groups for each of the three periods. 
The results were regarded as significant if p<0.05, one-tailed.  
 
Results 
The baseline physical characteristics of the participants at the 
start of the study are reported in Table 2. Figure 2 shows the 
systolic and diastolic BP for both the ExT and the ExC athletes. 
The negative pressure generated by the LBNP device on BP 
can clearly be seen in the systolic and diastolic fluctuations 
during the treatment sessions. Although there were slight 
changes in the HR and SpO2 measurements before and during 
each treatment session in the ExT and ExC groups, there were 
no significant differences in these physiological 
measurements; these differences are due to sample variation. 
Figure 3 illustrates the results of the blood lactate 
concentration (mmol/l) on Day One at baseline (Lac0), after a 
one hour (Lac1) intense exercise session, and after the first 30 
minute (Lac2) LBNP therapy session. The average blood 
lactate concentration (mmol/l) ratio (after vs. before) of the 
ExT group decreased after treatment, in comparison to the 
ExC group who did not receive treatment (0.57±0.23 vs. 
0.78±0.22, respectively, F(1;19)=9.420, p=0.006). No other 
significant differences were obtained.  
The CK measurements for both groups are shown in Figure 
4. Although there was an increase in CK enzyme activity 
following the first day’s training, the CK did not decrease 
significantly after three treatment sessions on the LBNP 
device (F(1;19)=0.172; p=0.683).  
Figure 5 shows the perceived recovery grading of both ExC 
and ExT athletes over a three day period during pre-treatment 
and post-treatment on the LBNP device (based on the questions 
in Table 1). The three pre-treatment questions were combined 
to get a pre-treatment recovery score, and the three post-
treatment questions were combined to get a post-treatment 
recovery score. There was a significant difference between the 
ExC and ExT groups (post-treatment score minus pre-treatment 
score) at all three time periods (0h p= 0.011; 24h p<0.001; 48h 
p=0.001). At post-treatment, after each of the 0 hour, 24 hour 
and 48 hour sessions, the ExT athletes reported a significant 
increase in their perceived degree of muscle feel, fatigue and 
recovery compared to the controls. The ExT group during each 
of the treatment periods indicated higher energy and recovery 
status than the ExC group.  
Discussion 
The decrease in the blood lactate concentration ratio of the 
treatment group compared to the control group (0.57±0.23 
vs. 0.78±0.22 mmol/l, respectively, p<0.001), following a 
single negative pressure treatment session, indicates that the 
use of the LBNP device succeeded in normalising lactate 
measurements more quickly, and may imply faster athlete 
rehabilitation and recovery. Per contra, the severity of 
muscle injury as indicated by the blood serum CK level of 
activity was not significantly reduced after three treatment 
sessions of negative pressure (F(1;19)=0.172; p=0.683). 
Negative vacuum pressure treatment did not affect the 
ongoing sports performance of the athletes, and no side 
effects were observed during the period the study was 
executed. All participants also form part of the same cricket 
academy and therefore their training schedules are fairly 
similar.  
Several physiological systems change when endurance 
training is induced (i.e. metabolic, cardiovascular, muscular, 
etc.), with the modification of lactate kinetic parameters a 
significant mediator to quantify the extent of exercise.[12] The 
mean blood lactate ratio between the control (ExC) and 
treatment (ExT) groups, directly after exercise vs. directly  
 
 
 
 
 
 
 
 
 
Fig.2. Systolic and diastolic blood pressure (N=22). M, Measurement.  
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Fig.3. Mean blood lactate concentration (mmol/l) on Day One at baseline (Lac0), after one hour of exercise (Lac1), and after 30 minutes 
therapy (Lac2) on the LBNP device (N=22). * Ratio significant at <0.01.  
. 
 
Fig.4. Mean creatine kinase enzyme activity on Day One at baseline (CK0), after one hour of exercise and the 1st therapy session (CK1), 
after the 2nd therapy session (CK2), and after the 3rd therapy session (CK3) (N=22). No significant decrease was found. 
 
Fig.5. Perceived recovery based on an ordinal scale indicating the post-treatment recovery score minus pre-treatment recovery score responses 
of both ExC and ExT athletes groups on the LBNP device, for the 0 hour, 24 hour and 48 hour sessions. Ordinal scale relates to questions A-
F in Table 1.* Significant at 5% level; ** Significant at 1% level.  
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after the 1st treatment session, demonstrated a significantly 
faster decrease in the treatment group, indicating the 
efficiency of the LBNP device to stimulate blood flow and 
as an aid in the removal of lactate.  
However, the daily academy training and competition 
programme the athletes followed, although fairly similar, 
may also have influenced the CK serum results. Again, the 
objective of evaluating negative pressure effect on recovery 
under acute athlete performance conditions is highlighted 
in this study.  
The stimulation of the circulatory system and the 
lymphatic vessels by the rhythmic alternating pressure of 
the LBNP device may conceivably mimic massage therapy. 
Sports massage is used by athletes with the belief that it 
will stimulate lymph flow and reduce muscle tightness in 
order to accelerate recovery and enhance performance. 
Improvement in muscle tone and a sense of feeling 
recovered and energised by the increased concentration of 
endorphins in the brain has also been advocated. Although 
many claimed benefits and numerous personal perceived 
experiences promote sports massage as the treatment of 
choice, research evidence on its appropriate use is scarce[10] 
with contradictory evidence that manual massage has any 
significant impact on the physiological and psychological 
factors associated with recovery following exercise.[9,10] 
Recovery may be reliably assessed both at pre- and post-
treatment with one-dimensional tools, such as individual 
evaluated numeric rating scales. Athletes who were treated 
with the LBNP device during their routine weekly training 
programme reported an increased subjective impression of 
treatment compared to that of the control athletes. A 
perceived improvement in muscle feeling and fatigue was 
seen, and they experienced increased training motivation 
and an enhanced feeling of recovery in general. The 
athletes described the treatments as ‘pleasant’ and rated 
their treatment sessions on the LBNP device as highly 
effective, reflecting the impression that the treatment 
sessions may help them to recover more quickly. At post-
treatment, after each of the 0 hour, 24 hour and 48 hour 
sessions, the ExT athletes reported a significant increase in 
their perceived degree of muscle feel, fatigue and recovery 
compared to the controls. The ExT group, during each of 
the treatment periods, indicated a higher energy and 
recovery status than the ExC group. The perceived 
perceptions of recovery that increased after each vacuum 
therapy session provides some support for the use of the 
LBNP device as a recovery strategy to improve the 
recovery state of the athlete. It has to be noted that the 
project specifically targeted short-term acute recovery and 
does not reflect on how the use of the LBNP device will be 
perceived over the long-term. The performance, 
motivation and subjective wellbeing of the athlete may 
well be further enhanced with the continuous use of the 
device. 
A limitation to this study is the short period the LBNP 
treatment was implemented, but the core emphasis was to 
determine acute athlete rehabilitation and recovery based 
on known measures of muscular recovery within a short 
period of time after high-intensity exercise. Beneficial to the 
device itself will be a further examination of its effectiveness 
and significance based on performance enhancement, 
recovery and rehabilitation of athletes, and the advanced 
development of various treatment programmes. 
 
Conclusion 
Based on this study, LBNP therapy implemented as an 
applied treatment within cricket players’ normal routine 
training and competition schedule, in an effort to assist in 
the recovery of players over a short period of time, seems to 
have a systemic effect in lowering serum lactate levels, but 
not CK levels. The enhanced long-term recovery of athletes 
using this device to replenish faster and recuperate more 
efficiently as advocated, are still unconfirmed. 
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